Drugs / B longum BB536
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02807064 Comparator | Dec 2016 → Jul 2018 | seasonal allergic rhinitis | University of Campania Luigi Vanvitelli | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B longum BB536 | “Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma.” PMID 28270216 ↗ Mar 2017 |
| Modality | Other / unclassified | “Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma.” PMID 28270216 ↗ Mar 2017 |
| Route | Oral | “Bifidobacteria 0.5 ml per os all days for 2 months” NCT02807064 ↗ |